APO Research
Talk to an analyst

APO RESEARCH · REPORT

MRI Contrast Agents

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global MRI Contrast Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025186 pages

Choose your research edition.

Industry ResearchMRI Contrast Agents Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal MRI Contrast Agents Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal MRI Contrast Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal MRI Contrast Agents Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal MRI Contrast Agents Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global MRI Contrast Agents market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for MRI Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for MRI Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for MRI Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for MRI Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of MRI Contrast Agents include Bayer, Guerbet Group, Bracco Imaging, GE Healthcare, BeiLu Pharma and Hengrui Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

On the production side, the report examines MRI Contrast Agents output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.

On the consumption side, the report analyzes sales of MRI Contrast Agents by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.

The report provides an overview of the global MRI Contrast Agents market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of MRI Contrast Agents and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents MRI Contrast Agents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the MRI Contrast Agents market size, projected growth trends, production technologies, key applications, and end-use industries.

MRI Contrast Agents Segment by Company

Bayer

Guerbet Group

Bracco Imaging

GE Healthcare

BeiLu Pharma

Hengrui Medicine

MRI Contrast Agents Segment by Type

Gadobutrol

Gadoterate Meglumine

Gadobenate Dimeglumine

Gadopentetate Dimeglumine

Gadoteridol

Gadodiamine

Others

MRI Contrast Agents Segment by Application

Hospitals

Clinics

MRI Contrast Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global MRI Contrast Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of MRI Contrast Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of MRI Contrast Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the MRI Contrast Agents market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global MRI Contrast Agents industry.

Chapter 3: Detailed analysis of MRI Contrast Agents market competition landscape. Including MRI Contrast Agents manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 7: Production/Production Value of MRI Contrast Agents by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 8: Consumption of MRI Contrast Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. MRI Contrast Agents Industry Trends Table 2. MRI Contrast Agents Industry Drivers Table 3. MRI Contrast Agents Industry Opportunities and Challenges Table 4. MRI Contrast Agents Industry Restraints Table 5. Global MRI Contrast Agents Production Value by Manufacturers (US$ Million) & (2021-2026) Table 6. Global MRI Contrast Agents Production Value Share by Manufacturers (2021-2026) Table 7. Global MRI Contrast Agents Production by Manufacturers (Liter) & (2021-2026) Table 8. Global MRI Contrast Agents Production Market Share by Manufacturers Table 9. Global MRI Contrast Agents Average Price (US$/mL) of Manufacturers (2021-2026) Table 10. Global MRI Contrast Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global MRI Contrast Agents Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global MRI Contrast Agents Manufacturers, Product Type & Application Table 13. Global MRI Contrast Agents Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global MRI Contrast Agents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Major Manufacturers of Gadobutrol Table 17. Major Manufacturers of Gadoterate Meglumine Table 18. Major Manufacturers of Gadobenate Dimeglumine Table 19. Major Manufacturers of Gadopentetate Dimeglumine Table 20. Major Manufacturers of Gadoteridol Table 21. Major Manufacturers of Gadodiamine Table 22. Major Manufacturers of Others Table 23. Global MRI Contrast Agents Production by Type 2021 VS 2025 VS 2032 (Liter) Table 24. Global MRI Contrast Agents Production by Type (2021-2026) & (Liter) Table 25. Global MRI Contrast Agents Production by Type (2027-2032) & (Liter) Table 26. Global MRI Contrast Agents Production Market Share by Type (2021-2026) Table 27. Global MRI Contrast Agents Production Market Share by Type (2027-2032) Table 28. Global MRI Contrast Agents Production Value by Type 2021 VS 2025 VS 2032 (Liter) Table 29. Global MRI Contrast Agents Production Value by Type (2021-2026) & (Liter) Table 30. Global MRI Contrast Agents Production Value by Type (2027-2032) & (Liter) Table 31. Global MRI Contrast Agents Production Value Market Share by Type (2021-2026) Table 32. Global MRI Contrast Agents Production Value Market Share by Type (2027-2032) Table 33. Major Manufacturers of Hospitals Table 34. Major Manufacturers of Clinics Table 35. Global MRI Contrast Agents Production by Application 2021 VS 2025 VS 2032 (Liter) Table 36. Global MRI Contrast Agents Production by Application (2021-2026) & (Liter) Table 37. Global MRI Contrast Agents Production by Application (2027-2032) & (Liter) Table 38. Global MRI Contrast Agents Production Market Share by Application (2021-2026) Table 39. Global MRI Contrast Agents Production Market Share by Application (2027-2032) Table 40. Global MRI Contrast Agents Production Value by Application 2021 VS 2025 VS 2032 (Liter) Table 41. Global MRI Contrast Agents Production Value by Application (2021-2026) & (Liter) Table 42. Global MRI Contrast Agents Production Value by Application (2027-2032) & (Liter) Table 43. Global MRI Contrast Agents Production Value Market Share by Application (2021-2026) Table 44. Global MRI Contrast Agents Production Value Market Share by Application (2027-2032) Table 45. Bayer Company Information Table 46. Bayer Business Overview Table 47. Bayer MRI Contrast Agents Production (Liter), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 48. Bayer MRI Contrast Agents Product Portfolio Table 49. Bayer Recent Development Table 50. Guerbet Group Company Information Table 51. Guerbet Group Business Overview Table 52. Guerbet Group MRI Contrast Agents Production (Liter), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 53. Guerbet Group MRI Contrast Agents Product Portfolio Table 54. Guerbet Group Recent Development Table 55. Bracco Imaging Company Information Table 56. Bracco Imaging Business Overview Table 57. Bracco Imaging MRI Contrast Agents Production (Liter), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 58. Bracco Imaging MRI Contrast Agents Product Portfolio Table 59. Bracco Imaging Recent Development Table 60. GE Healthcare Company Information Table 61. GE Healthcare Business Overview Table 62. GE Healthcare MRI Contrast Agents Production (Liter), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 63. GE Healthcare MRI Contrast Agents Product Portfolio Table 64. GE Healthcare Recent Development Table 65. BeiLu Pharma Company Information Table 66. BeiLu Pharma Business Overview Table 67. BeiLu Pharma MRI Contrast Agents Production (Liter), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 68. BeiLu Pharma MRI Contrast Agents Product Portfolio Table 69. BeiLu Pharma Recent Development Table 70. Hengrui Medicine Company Information Table 71. Hengrui Medicine Business Overview Table 72. Hengrui Medicine MRI Contrast Agents Production (Liter), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 73. Hengrui Medicine MRI Contrast Agents Product Portfolio Table 74. Hengrui Medicine Recent Development Table 75. Global MRI Contrast Agents Production by Region: 2021 VS 2025 VS 2032 (Liter) Table 76. Global MRI Contrast Agents Production by Region (2021-2026) & (Liter) Table 77. Global MRI Contrast Agents Production Market Share by Region (2021-2026) Table 78. Global MRI Contrast Agents Production Forecast by Region (2027-2032) & (Liter) Table 79. Global MRI Contrast Agents Production Market Share Forecast by Region (2027-2032) Table 80. Global MRI Contrast Agents Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 81. Global MRI Contrast Agents Production Value by Region (2021-2026) & (US$ Million) Table 82. Global MRI Contrast Agents Production Value Share by Region (2021-2026) Table 83. Global MRI Contrast Agents Production Value by Region (2027-2032) & (US$ Million) Table 84. Global MRI Contrast Agents Production Value Share by Region: (2027-2032) & (US$ Million) Table 85. Global MRI Contrast Agents Market Average Price (US$/mL) by Region (2021-2026) Table 86. Global MRI Contrast Agents Market Average Price (US$/mL) by Region (2027-2032) Table 87. Global MRI Contrast Agents Consumption by Region: 2021 VS 2025 VS 2032 (Liter) Table 88. Global MRI Contrast Agents Consumption by Region (2021-2026) & (Liter) Table 89. Global MRI Contrast Agents Consumption Market Share by Region (2021-2026) Table 90. Global MRI Contrast Agents Consumption Forecasted by Region (2027-2032) & (Liter) Table 91. Global MRI Contrast Agents Consumption Forecasted Market Share by Region (2027-2032) Table 92. North America MRI Contrast Agents Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Liter) Table 93. North America MRI Contrast Agents Consumption by Country (2021-2026) & (Liter) Table 94. North America MRI Contrast Agents Consumption by Country (2027-2032) & (Liter) Table 95. Europe MRI Contrast Agents Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Liter) Table 96. Europe MRI Contrast Agents Consumption by Country (2021-2026) & (Liter) Table 97. Europe MRI Contrast Agents Consumption by Country (2027-2032) & (Liter) Table 98. Asia Pacific MRI Contrast Agents Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Liter) Table 99. Asia Pacific MRI Contrast Agents Consumption by Country (2021-2026) & (Liter) Table 100. Asia Pacific MRI Contrast Agents Consumption by Country (2027-2032) & (Liter) Table 101. South America MRI Contrast Agents Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Liter) Table 102. South America MRI Contrast Agents Consumption by Country (2021-2026) & (Liter) Table 103. South America MRI Contrast Agents Consumption by Country (2027-2032) & (Liter) Table 104. Middle East & Africa MRI Contrast Agents Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Liter) Table 105. Middle East & Africa MRI Contrast Agents Consumption by Country (2021-2026) & (Liter) Table 106. Middle East & Africa MRI Contrast Agents Consumption by Country (2027-2032) & (Liter) Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. MRI Contrast Agents Distributors List Table 110. MRI Contrast Agents Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. MRI Contrast Agents Product Image Figure 2. Global MRI Contrast Agents Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global MRI Contrast Agents Production Value (2021-2032) & (US$ Million) Figure 4. Global MRI Contrast Agents Production Capacity (2021-2032) & (Liter) Figure 5. Global MRI Contrast Agents Production (2021-2032) & (Liter) Figure 6. Global MRI Contrast Agents Average Price (US$/mL) & (2021-2032) Figure 7. Global Top 5 and 10 MRI Contrast Agents Players Market Share by Production Value in 2025 Figure 8. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Gadobutrol Image Figure 10. Gadoterate Meglumine Image Figure 11. Gadobenate Dimeglumine Image Figure 12. Gadopentetate Dimeglumine Image Figure 13. Gadoteridol Image Figure 14. Gadodiamine Image Figure 15. Others Image Figure 16. Global MRI Contrast Agents Production by Type (2021 VS 2025 VS 2032) & (Liter) Figure 17. Global MRI Contrast Agents Production Market Share 2021 VS 2025 VS 2032 Figure 18. Global MRI Contrast Agents Production Market Share by Type (2021-2032) Figure 19. Global MRI Contrast Agents Production Value by Type (2021 VS 2025 VS 2032) & (Liter) Figure 20. Global MRI Contrast Agents Production Value Share 2021 VS 2025 VS 2032 Figure 21. Global MRI Contrast Agents Production Value Share by Type (2021-2032) Figure 22. Hospitals Image Figure 23. Clinics Image Figure 24. Global MRI Contrast Agents Production by Application (2021 VS 2025 VS 2032) & (Liter) Figure 25. Global MRI Contrast Agents Production Market Share 2021 VS 2025 VS 2032 Figure 26. Global MRI Contrast Agents Production Market Share by Application (2021-2032) Figure 27. Global MRI Contrast Agents Production Value by Application (2021 VS 2025 VS 2032) & (Liter) Figure 28. Global MRI Contrast Agents Production Value Share 2021 VS 2025 VS 2032 Figure 29. Global MRI Contrast Agents Production Value Share by Application (2021-2032) Figure 30. Global MRI Contrast Agents Production by Region: 2021 VS 2025 VS 2032 (Liter) Figure 31. Global MRI Contrast Agents Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global MRI Contrast Agents Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global MRI Contrast Agents Production Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America MRI Contrast Agents Production Value (2021-2032) & (US$ Million) Figure 35. Europe MRI Contrast Agents Production Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific MRI Contrast Agents Production Value (2021-2032) & (US$ Million) Figure 37. South America MRI Contrast Agents Production Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa MRI Contrast Agents Production Value (2021-2032) & (US$ Million) Figure 39. North America MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 40. North America MRI Contrast Agents Consumption Market Share by Country (2021-2032) Figure 41. U.S. MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 42. Canada MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 43. Mexico MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 44. Europe MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 45. Europe MRI Contrast Agents Consumption Market Share by Country (2021-2032) Figure 46. Germany MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 47. France MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 48. U.K. MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 49. Italy MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 50. Netherlands MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 51. Asia Pacific MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 52. Asia Pacific MRI Contrast Agents Consumption Market Share by Country (2021-2032) Figure 53. China MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 54. Japan MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 55. South Korea MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 56. Southeast Asia MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 57. India MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 58. Australia MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 59. South America MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 60. South America MRI Contrast Agents Consumption Market Share by Country (2021-2032) Figure 61. Brazil MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 62. Argentina MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 63. Chile MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 64. Colombia MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 65. Middle East & Africa MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 66. Middle East & Africa MRI Contrast Agents Consumption Market Share by Country (2021-2032) Figure 67. Egypt MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 68. South Africa MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 69. Israel MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 70. Türkiye MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 71. GCC Countries MRI Contrast Agents Consumption and Growth Rate (2021-2032) & (Liter) Figure 72. MRI Contrast Agents Value Chain Figure 73. Manufacturing Cost Structure Figure 74. MRI Contrast Agents Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Gadobutrol
  • Gadoterate Meglumine
  • Gadobenate Dimeglumine
  • Gadopentetate Dimeglumine
  • Gadoteridol
  • Gadodiamine
  • Others
Applications
  • Hospitals
  • Clinics
Companies covered
  • Bayer
  • Guerbet Group
  • Bracco Imaging
  • GE Healthcare
  • BeiLu Pharma
  • Hengrui Medicine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global MRI Contrast Agents Production Value Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global MRI Contrast Agents Production Capacity Estimates and Forecasts (2021-2032)
  5. 1.2.3 Global MRI Contrast Agents Production Estimates and Forecasts (2021-2032)
  6. 1.2.4 Global MRI Contrast Agents Market Average Price (2021-2032)
  7. 1.3 Assumptions and Limitations
  8. 1.4 Study Goals and Objectives
2 Global MRI Contrast Agents Market Dynamics
  1. 2.1 MRI Contrast Agents Industry Trends
  2. 2.2 MRI Contrast Agents Industry Drivers
  3. 2.3 MRI Contrast Agents Industry Opportunities and Challenges
  4. 2.4 MRI Contrast Agents Industry Restraints
3 MRI Contrast Agents Market by Manufacturers
  1. 3.1 Global MRI Contrast Agents Production Value by Manufacturers (2021-2026)
  2. 3.2 Global MRI Contrast Agents Production by Manufacturers (2021-2026)
  3. 3.3 Global MRI Contrast Agents Average Price by Manufacturers (2021-2026)
  4. 3.4 Global MRI Contrast Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global MRI Contrast Agents Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global MRI Contrast Agents Manufacturers, Product Type & Application
  7. 3.7 Global MRI Contrast Agents Manufacturers Established Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global MRI Contrast Agents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 MRI Contrast Agents Players Market Share by Production Value in 2025
  11. 3.8.3 2025 MRI Contrast Agents Tier 1, Tier 2, and Tier 3
4 MRI Contrast Agents Market by Type
  1. 4.1 MRI Contrast Agents Type Introduction
  2. 4.1.1 Gadobutrol
  3. 4.1.2 Gadoterate Meglumine
  4. 4.1.3 Gadobenate Dimeglumine
  5. 4.1.4 Gadopentetate Dimeglumine
  6. 4.1.5 Gadoteridol
  7. 4.1.6 Gadodiamine
  8. 4.1.7 Others
  9. 4.2 Global MRI Contrast Agents Production by Type
  10. 4.2.1 Global MRI Contrast Agents Production by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global MRI Contrast Agents Production by Type (2021-2032)
  12. 4.2.3 Global MRI Contrast Agents Production Market Share by Type (2021-2032)
  13. 4.3 Global MRI Contrast Agents Production Value by Type
  14. 4.3.1 Global MRI Contrast Agents Production Value by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global MRI Contrast Agents Production Value by Type (2021-2032)
  16. 4.3.3 Global MRI Contrast Agents Production Value Market Share by Type (2021-2032)
5 MRI Contrast Agents Market by Application
  1. 5.1 MRI Contrast Agents Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.2 Global MRI Contrast Agents Production by Application
  5. 5.2.1 Global MRI Contrast Agents Production by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global MRI Contrast Agents Production by Application (2021-2032)
  7. 5.2.3 Global MRI Contrast Agents Production Market Share by Application (2021-2032)
  8. 5.3 Global MRI Contrast Agents Production Value by Application
  9. 5.3.1 Global MRI Contrast Agents Production Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global MRI Contrast Agents Production Value by Application (2021-2032)
  11. 5.3.3 Global MRI Contrast Agents Production Value Market Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Bayer
  2. 6.1.1 Bayer Company Information
  3. 6.1.2 Bayer Business Overview
  4. 6.1.3 Bayer MRI Contrast Agents Production, Value and Gross Margin (2021-2026)
  5. 6.1.4 Bayer MRI Contrast Agents Product Portfolio
  6. 6.1.5 Bayer Recent Developments
  7. 6.2 Guerbet Group
  8. 6.2.1 Guerbet Group Company Information
  9. 6.2.2 Guerbet Group Business Overview
  10. 6.2.3 Guerbet Group MRI Contrast Agents Production, Value and Gross Margin (2021-2026)
  11. 6.2.4 Guerbet Group MRI Contrast Agents Product Portfolio
  12. 6.2.5 Guerbet Group Recent Developments
  13. 6.3 Bracco Imaging
  14. 6.3.1 Bracco Imaging Company Information
  15. 6.3.2 Bracco Imaging Business Overview
  16. 6.3.3 Bracco Imaging MRI Contrast Agents Production, Value and Gross Margin (2021-2026)
  17. 6.3.4 Bracco Imaging MRI Contrast Agents Product Portfolio
  18. 6.3.5 Bracco Imaging Recent Developments
  19. 6.4 GE Healthcare
  20. 6.4.1 GE Healthcare Company Information
  21. 6.4.2 GE Healthcare Business Overview
  22. 6.4.3 GE Healthcare MRI Contrast Agents Production, Value and Gross Margin (2021-2026)
  23. 6.4.4 GE Healthcare MRI Contrast Agents Product Portfolio
  24. 6.4.5 GE Healthcare Recent Developments
  25. 6.5 BeiLu Pharma
  26. 6.5.1 BeiLu Pharma Company Information
  27. 6.5.2 BeiLu Pharma Business Overview
  28. 6.5.3 BeiLu Pharma MRI Contrast Agents Production, Value and Gross Margin (2021-2026)
  29. 6.5.4 BeiLu Pharma MRI Contrast Agents Product Portfolio
  30. 6.5.5 BeiLu Pharma Recent Developments
  31. 6.6 Hengrui Medicine
  32. 6.6.1 Hengrui Medicine Company Information
  33. 6.6.2 Hengrui Medicine Business Overview
  34. 6.6.3 Hengrui Medicine MRI Contrast Agents Production, Value and Gross Margin (2021-2026)
  35. 6.6.4 Hengrui Medicine MRI Contrast Agents Product Portfolio
  36. 6.6.5 Hengrui Medicine Recent Developments
7 Global MRI Contrast Agents Production by Region
  1. 7.1 Global MRI Contrast Agents Production by Region: 2021 VS 2025 VS 2032
  2. 7.2 Global MRI Contrast Agents Production by Region (2021-2032)
  3. 7.2.1 Global MRI Contrast Agents Production by Region (2021-2026)
  4. 7.2.2 Global MRI Contrast Agents Production Forecast by Region (2027-2032)
  5. 7.3 Global MRI Contrast Agents Production by Region: 2021 VS 2025 VS 2032
  6. 7.4 Global MRI Contrast Agents Production Value by Region (2021-2032)
  7. 7.4.1 Global MRI Contrast Agents Production Value by Region (2021-2026)
  8. 7.4.2 Global MRI Contrast Agents Production Value by Region (2027-2032)
  9. 7.5 Global MRI Contrast Agents Market Price Analysis by Region (2021-2032)
  10. 7.6 Regional Production Value Trends (2021-2032)
  11. 7.6.1 North America MRI Contrast Agents Production Value (2021-2032)
  12. 7.6.2 Europe MRI Contrast Agents Production Value (2021-2032)
  13. 7.6.3 Asia-Pacific MRI Contrast Agents Production Value (2021-2032)
  14. 7.6.4 South America MRI Contrast Agents Production Value (2021-2032)
  15. 7.6.5 Middle East & Africa MRI Contrast Agents Production Value (2021-2032)
8 Global MRI Contrast Agents Consumption by Region
  1. 8.1 Global MRI Contrast Agents Consumption by Region: 2021 VS 2025 VS 2032
  2. 8.2 Global MRI Contrast Agents Consumption by Region (2021-2032)
  3. 8.2.1 Global MRI Contrast Agents Consumption by Region (2021-2026)
  4. 8.2.2 Global MRI Contrast Agents Consumption by Region (2027-2032)
  5. 8.3 North America
  6. 8.3.1 North America MRI Contrast Agents Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 8.3.2 North America MRI Contrast Agents Consumption by Country (2021-2032)
  8. 8.3.3 U.S.
  9. 8.3.4 Canada
  10. 8.3.5 Mexico
  11. 8.4 Europe
  12. 8.4.1 Europe MRI Contrast Agents Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 8.4.2 Europe MRI Contrast Agents Consumption by Country (2021-2032)
  14. 8.4.3 Germany
  15. 8.4.4 France
  16. 8.4.5 U.K.
  17. 8.4.6 Italy
  18. 8.4.7 Netherlands
  19. 8.5 Asia Pacific
  20. 8.5.1 Asia Pacific MRI Contrast Agents Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 8.5.2 Asia Pacific MRI Contrast Agents Consumption by Country (2021-2032)
  22. 8.5.3 China
  23. 8.5.4 Japan
  24. 8.5.5 South Korea
  25. 8.5.6 Southeast Asia
  26. 8.5.7 India
  27. 8.5.8 Australia
  28. 8.6 South America
  29. 8.6.1 South America MRI Contrast Agents Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 8.6.2 South America MRI Contrast Agents Consumption by Country (2021-2032)
  31. 8.6.3 Brazil
  32. 8.6.4 Argentina
  33. 8.6.5 Chile
  34. 8.6.6 Colombia
  35. 8.7 Middle East & Africa
  36. 8.7.1 Middle East & Africa MRI Contrast Agents Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  37. 8.7.2 Middle East & Africa MRI Contrast Agents Consumption by Country (2021-2032)
  38. 8.7.3 Egypt
  39. 8.7.4 South Africa
  40. 8.7.5 Israel
  41. 8.7.6 Türkiye
  42. 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
  1. 9.1 MRI Contrast Agents Value Chain Analysis
  2. 9.1.1 MRI Contrast Agents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 MRI Contrast Agents Production Mode & Process
  6. 9.2 MRI Contrast Agents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 MRI Contrast Agents Distributors
  9. 9.2.3 MRI Contrast Agents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst